Johnson & Johnson (JNJ) COVID-19 Vaccine Roll-out to Resume in Europe Following EMA Review
Go back to Johnson & Johnson (JNJ) COVID-19 Vaccine Roll-out to Resume in Europe Following EMA ReviewJohnson & Johnson (NYSE: JNJ) | Delayed: 145.42 -0.32 (0.22%) | |||||
---|---|---|---|---|---|---|
Previous Close | $145.74 | 52 Week High | $126.07 | |||
Open | $146.15 | 52 Week Low | $94.28 | |||
Day High | $146.16 | P/E | 30.23 | |||
Day Low | $144.54 | EPS | $4.81 | |||
Volume | 854,380 |